351416-47-2

351416-47-2 structure
351416-47-2 structure
  • Name: Nemorosone
  • Chemical Name: Nemorosone
  • CAS Number: 351416-47-2
  • Molecular Formula: C33H42O4
  • Molecular Weight: 502.684
  • Catalog: Signaling Pathways Apoptosis Apoptosis
  • Create Date: 2021-08-27 08:08:39
  • Modify Date: 2024-01-11 16:41:27
  • Nemorosone is the main component of the floral resin of Clusia rosea. Nemorosone has an antiproliferative effect on cancer cells. Nemorosone induces apoptosis in HT-29 and LoVo cells[1][2].

Name Nemorosone
Synonyms (1R,5S,7S)-5-Benzoyl-4-hydroxy-6,6-dimethyl-1,3,7-tris(3-methyl-2-buten-1-yl)bicyclo[3.3.1]non-3-ene-2,9-dione
Bicyclo[3.3.1]non-3-ene-2,9-dione, 5-benzoyl-4-hydroxy-6,6-dimethyl-1,3,7-tris(3-methyl-2-buten-1-yl)-, (1R,5S,7S)-
Nemorosone
Description Nemorosone is the main component of the floral resin of Clusia rosea. Nemorosone has an antiproliferative effect on cancer cells. Nemorosone induces apoptosis in HT-29 and LoVo cells[1][2].
Related Catalog
Target

apoptosis[1]

In Vitro Nemorosone (0-50 μM; 24-72 h) inhibits the proliferation of HT-29 and LoVo cells with IC50s of 25.7-27.1 μM, 22.8-64.3 μM, respectively[1]. Nemorosone (25.7 μM for HT-29; 22.8 μM for LoVo; 24, 48 hours) increases the percentage of G0/G1 phase cells[1]. Nemorosone (25.7 μM for HT-29; 22.8 μM for LoVo; 24, 48 hours) induces apoptosis in both cell lines[1]. Cell Proliferation Assay[1] Cell Line: HT-29 and LoVo cells Concentration: 0-50 μM Incubation Time: 24-72 h Result: Inhibited the proliferation of HT-29 and LoVo cells with IC50s of 25.7-27.1 μM, 22.8-64.3 μM, respectively. Cell Cycle Analysis[1] Cell Line: HT-29 and LoVo cells Concentration: 25.7 μM for HT-29; 22.8 μM for LoVo Incubation Time: 24, 48 hours Result: Increased the percentage of G0/G1 phase cells. Apoptosis Analysis[1] Cell Line: HT-29 and LoVo cells Concentration: 25.7 μM for HT-29; 22.8 μM for LoVo Incubation Time: 24, 48 hours Result: Induced apoptosis in both cell lines.
In Vivo Nemorosone (50 mg/kg; daily i.p. for 28 days) shows a significant growth-inhibitory effect in pancreatic cancer xenografts[2]. Animal Model: Athymic NMRI nu/nu nude mices (6 to 8 week old female), which had 100 mm3 MIA-PaCa-2 xenograft tumor[2] Dosage: 50 mg/kg Administration: Daily i.p. injections for 28 days Result: Showed a significant growth-inhibitory effect in pancreatic cancer xenografts[2].
References

[1]. Frión-Herrera Y, Gabbia D, Scaffidi M, et al. The Cuban Propolis Component Nemorosone Inhibits Proliferation and Metastatic Properties of Human Colorectal Cancer Cells. Int J Mol Sci. 2020;21(5):1827. Published 2020 Mar 6.

[2]. Wolf RJ, et al. In vivo activity and pharmacokinetics of nemorosone on pancreatic cancer xenografts. PLoS One. 2013;8(9):e74555. Published 2013 Sep 5.

Density 1.1±0.1 g/cm3
Boiling Point 608.9±55.0 °C at 760 mmHg
Molecular Formula C33H42O4
Molecular Weight 502.684
Flash Point 336.1±28.0 °C
Exact Mass 502.308319
LogP 10.69
Vapour Pressure 0.0±1.8 mmHg at 25°C
Index of Refraction 1.553
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.